Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NSAID Response and Central Sensitization of Pain in Women With Dysmenorrhea
NCT05900336Phase 4Completed
- Sponsor
- McLean Hospital
- Start
- Mar 2024
- Primary completion
- Aug 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of Aprol in dysmenorrhea, sponsored by McLean Hospital. Started Mar 2024; status: completed.
02
Drugs
Aprol
03
Conditions
dysmenorrhea
Beyond the preview
Go deeper on NCT05900336.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05900336.